Sanofi gets USFDA nod for ASMD drug Xenpozyme Ruchika Sharma2 Sept 2022 3:57 PM ISTASMD, historically known as Niemann-Pick disease types A, A/B, and B, is an extremely rare, progressive genetic disease with significant morbidity and...
Sanofi stops breast cancer drug Amcenestrant Clinical Development Program Roshni Dhar19 Aug 2022 6:30 PM ISTPharma major, Sanofi, has announced the discontinuation of the global clinical development program of amcenestrant, an investigational oral selective...
Sanofi halts breast cancer drug Amcenestrant clinical development program Ruchika Sharma18 Aug 2022 1:15 PM ISTParis: Pharma major, Sanofi, has announced the discontinuation of the global clinical development program of amcenestrant, an investigational oral...
Sanofi, Innovent Biologics ink pact to accelerate development of oncology medicines in China Ruchika Sharma7 Aug 2022 12:30 PM ISTIn addition to the collaboration and license agreement, Sanofi will invest €300 million in Innovent through subscription of new common shares.
Sanofi gets CDSCO Panel okay to study Dupilumab Dr. Divya Colin19 July 2022 6:00 PM ISTNew Delhi: Directing to include all Serious Adverse Events (SAEs) and adverse events (AEs) of test drug in the informed consent document, the Subject...
Sanofi Dupixent Phase 3 trial shows positive results in children with eosinophilic esophagitis as young as age 1 Ruchika Sharma16 July 2022 12:30 PM ISTEoE is a chronic inflammatory disease that damages the esophagus and prevents it from working properly.
Sanofi Global Health unveils new brand Impact for distribution of 30 medicines in low-income countries Ruchika Sharma4 July 2022 5:44 PM ISTConsidered essential by the World Health Organization, the medicines cover a wide range of therapeutic areas, including diabetes, cardiovascular...
USFDA places clinical hold on Phase 3 Tolebrutinib studies: Sanofi Ruchika Sharma2 July 2022 12:45 PM ISTThe FDA action was based on a limited number of cases of drug-induced liver injury that have been identified with tolebrutinib exposure in Phase 3...
GSK-Sanofi variant-specific COVID vaccine found effective against Omicron Ruchika Sharma24 Jun 2022 4:30 PM ISTParis: Sanofi and GSK today announced positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta (B.1.351) vaccine...
'Golden time for India to emerge as innovator nation in biopharma sector' Ruchika Sharma23 Jun 2022 3:30 PM ISTWashington: Post COVID19, it's a golden time for India to emerge as an innovator nation in the biopharma sector, organiser of the annual India-US...
Upgraded version of COVID booster shot has potential against main variants: Sanofi Ruchika Sharma13 Jun 2022 3:02 PM ISTParis: French drugmaker Sanofi said on Monday an upgraded version of the COVID-19 vaccine candidate it is developing with GSK showed potential in...
Sanofi Dupixent wins USFDA nod for atopic dermatitis Ruchika Sharma8 Jun 2022 1:00 PM ISTDupixent is administered as an injection under the skin (subcutaneous injection) at different injection sites.
